Centers for Disease Control and Prevention
Coordinating Center for Infectious Diseases, Mail Stop G-23
Atlanta, Georgia 30333
HUMAN
IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1)
RAPID TESTING LABORATORY PRACTICES QUESTIONNAIRE FOR
NATIONAL AND INTERNATIONAL PARTICIPANTS
MPEP Identification
No.: □□□□□
Facility/Testing Site Name:
_________________________________________________
Street:___________________________________________________________________
City:_________________________________________
State/Province:___________________
ZIP /Postal
Code:_____________________
Country:____________________________
Telephone No.:
(______)_________-________Fax No.:
(_____)_______-___________
E-mail Address:
________________________________________________________________________
Person completing form:
Name:_____________________________________________________________
Title: ________________________________________________________
Public reporting of this
collection of information is estimated to average 20 minutes per
response, including the time for reviewing instructions, searching
existing data sources, gathering and maintaining the data needed,
and completing and reviewing the collection of information. An
agency may not conduct or sponsor, and a person is not required to
respond to a collection of information unless it displays a
currently valid OMB control number. Send comments regarding this
burden estimate or any other aspect of this collection of
information, including suggestions for reducing this burden to
CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74,
Atlanta, GA 30333; ATTN: PRA (0920-0595)
RETURNING THE QUESTIONNAIRE BOOKLET
PLEASE NOTE:
If you have entered and submitted your answers online,
Please DO NOT return this booklet!
DEADLINE FOR SUBMISSION: ______________ __, 2006
The website for online data submission of results is:
https://www.phppo.cdc.gov/mpep/results/login.aspx
You will need your MPEP identification number and password.
For those laboratories that choose to submit their answers on paper, an addressed envelope has been provided to mail the completed booklet to the MPEP. If you use the envelope provided, please mail your questionnaire booklet so that it reaches the MPEP Survey Coordinator at Constella Group, Inc. by the deadline indicated on the cover. If you use your own envelope, please send your questionnaire by the deadline to:
MPEP Survey Coordinator
Constella Group, Inc.
3 Corporate Blvd.
Suite 600
Atlanta, GA 30329
If you have any questions about submitting your questionnaire, please contact the
HIV Rapid Testing Project Coordinator, Leigh Vaughan:
telephone (404) 718-1005
email [email protected]
MPEP Identification No. □□□□□
1. a) Please indicate the primary classification of your
facility/testing site.
(Check one
primary classification.)
□ Blood/plasma donor center □ HMO
(includes mobile units/vans used □ HIV Counseling and testing site/Clinic site
for donor blood collection) □ HIV Counseling and testing site/Field site
□ Drug use treatment center □ STD clinic
□ Family planning center Health dept: □ State/Province □ Other
□ Community based organization (CBO) □ Independent laboratory
□ Medical examiner/Coroner’s office □ Military (other than hospital)
□ Physician office □ Mobile unit/van (other than blood donor donation)
□ Oral health □ Hospice
□ Correctional facility/prison
Hospital (Indicate all applicable sections/locations within the hospital, as listed below:)
□ Admissions □ Blood Bank □ Central Laboratory
□ Emergency Room □ Labor/Delivery □ Ward/Floor
□ Employee health/infection control □ Other Hospital Section (specify) _________
□ Other testing site classification (specify):____________________________
b) Which of the following services does your organization provide? (Check all that apply.)
□ Medical care for people with HIV/AIDS
□ Social services for people with HIV/AIDS
□ HIV/AIDS prevention and education
□ Reproductive health
□ STD treatment/prevention
□ Maternal and child health
□ Mental/behavioral health
□ Hemophilia care
□ Comprehensive/general health clinic
□ Drug treatment
□ Housing assistance
□ Food bank
□ Other (please specify): _______________________________________________
1. c) Does your facility currently perform HIV rapid testing?
□ Yes, go to question 1e
□ No, please answer 1d and return your survey.
d) If your facility does not perform HIV rapid testing, why not?
□ Our facility is in a low prevalence area
□ Fears about test performance such as false positives
□ Lack of funding to purchase tests
□ Lack of interest
□ Other: ____________________________________
e) When did your facility begin to perform HIV rapid testing?
DATE: year □□□□
month (circle
one) Jan Feb Mar Apr May June
July Aug Sept Oct Nov Dec
□
date unknown, but > 5
years
□ date unknown
2. a) For what purpose(s) do you offer HIV rapid testing? (Check all that apply.)
□ Initial screen for diagnosis
□ Voluntary HIV testing (outpatients/clients)
□ Testing pregnant women of unknown HIV status at the time of delivery
□ For making decisions on post-exposure treatment for healthcare workers after
an accidental exposure
□ Emergency room screening
□ Other ______________________________
b) What is the target population for your rapid testing program?
Any client/patient who requests an HIV test □Yes □No
Any high school/college student □Yes □No
Any high risk client/patient □Yes □No
Certain types or categories of high risk client □Yes □No
If “Yes” to high risk client/patients, please specify (Check all that apply):
□ Gay/bisexual men or men who have sex with men
□ High risk women (e.g., sex workers)
□ Injection drug users
□ Adolescents
□ Homeless individuals
□ African Americans
□ Hispanic or Latino
□ Other (please specify): _________________________________________________
c) Approximately how many unique clients does your organization serve per year, across all
programs, onsite and offsite? ____________________________
2.
d) Approximately what percentage of clients/patients at your
organization
(round to nearest whole number):
Percent Don’t know*
Have incomes at or below the Federal poverty level§? ______ ____
Are African American? ______ ____
Are Hispanic or Latino? ______ ____
Are White/Caucasian? ______ ____
Are HIV-positive? ______ ____
* information not available to laboratory
§ Note: The federal poverty guideline is $9,570 for a 1-person household (HH), $12,830 for a 2-person HH,
$16,000 for a 3-person HH, and $19,350 for a 4-person HH)
e) Who PRIMARILY funds your testing site? (Check only ONE BEST answer)
□ CDC funded □ Federal, other than CDC
□ State/Province funded □ Private, non-profit
□ County, city or other government □ Private, for profit
(non-federal, non-state) □ Other (please specify):________________
3. a) Of all HIV testing performed in your facility over the past year, what percentage
was performed using HIV rapid test kits?
□ <5% □ 21-30% □ 61-74%
□ 6-10% □ 31-40% □ 75-99%
□ 11-15% □ 41-50% □ 100%
□ 16-20% □ 51-60%
b) How many client/patient specimens were tested using HIV rapid tests in your
facility during the most recent representative MONTH?
_________ number of specimens per MONTH
c) Of the specimens reported in 3b above, how many were initially reactive
(preliminary positive) during the same most recent representative MONTH?
_________ total number of initially
reactive (preliminary positive)
specimens per MONTH
d) Of the above (see answer 3c) initially reactive (preliminary positive) HIV rapid test results for which a confirmatory test was performed, how many were confirmed as positive?
_________ OR □ Confirmatory testing is not required
□ We do not perform confirmatory testing
□ We have not had any reactive (preliminary positive)
HIV rapid test results
□ N/A – client is referred elsewhere for confirmatory
testing (results unknown)
3. e) In the last 6 months, how many persons received preliminary positive results,
but did not return for confirmatory test results?
________ # of persons with initially ________ total # of persons not
reactive results returning for confirmatory results
□ N/A, we do not require confirmatory testing.
□ N/A, persons are sent elsewhere for confirmatory testing and
we do not receive those results.
□ No information available to us on confirmatory testing.
f) If HIV screening tests other than rapid tests are offered in your facility, what percentage of patients/clients in the last 6 months with preliminary positive results from these other tests do
not return for confirmatory results?
□ N/A, other HIV tests are not performed in our facility.
□ N/A, confirmatory testing is not required for our other (not rapid) HIV screening test(s).
□ N/A, persons sent elsewhere for confirmatory testing and we do not receive test results.
□ Don’t know; no information available on confirmatory testing for our other (not rapid) HIV
screening test(s).
4. a) Does your facility provide anonymous HIV rapid testing?
□ Yes
□
No
b) Does your facility have procedures for protecting the confidentiality of HIV results?
□ Yes
□ No
What test kit(s) do you currently use for HIV rapid testing? (Check all that apply.)
Abbott: |
□ |
(0101) |
Determine HIV-1/2 |
|
Genelabs Diagnostics: |
□ |
(0601) |
HIV-Spot |
Bio-Rad: |
□ □ |
(0301) (0302) |
Multispot HIV-1/HIV-2 Genie II HIV-1/HIV-2 |
J. Mitra & Co. Ltd: |
□ |
(1301) |
HIV- TRIDOT
|
|
Chembio |
□ (0401)
□ □ |
(0401)
(0402) (0403) |
Sure Check HIV (previously Hemastrip HIV 1/2) HIV 1/2 Stat-Pak (Cassette) HIV 1/2 Stat-Pak (Dipstick) |
OraSure: |
□ □ |
(0801) (0802) |
OraQuick Rapid HIV-1 Ab Test OraQuick ADVANCE Rapid HIV-1/2 Antibody test |
|
Efoora : |
□ |
(1201) |
HIV Rapid Test |
Trinity Biotech: |
□ |
(0901) |
Capillus HIV |
|
Fujirebio: |
□ |
(0501) |
Serodia-HIV-1/2 |
|
□ |
(0902) |
SeroCard HIV |
|
|
□ |
(0502) |
Espline HIV-1/2 |
|
□ |
(0903) |
Uni-Gold HIV |
|
MedMira: |
□ |
(0701) |
Reveal G2 Rapid HIV-1 Antibody Test |
|
□ |
(0904) |
Uni-Gold Recombigen HIV |
|
|
□ |
(0702) |
Reveal Rapid HIV-1 Antibody Test |
Other (please specify both |
□ |
(9900) |
_________________________ _________________________ |
|
|
□ |
(0703) |
MedMira Rapid HIV Test (Canada only) |
manufacturer & kit) |
|
|
|
6. What sample type(s) do you currently use for HIV rapid testing? (Check all that apply.)
□ Serum □ Whole blood, finger-stick
□ Plasma □ Whole blood, venous
□ Oral fluid (from swabbing gums) □ Other (please specify): _______________________
7. a) Where are specimens collected and HIV rapid testing performed? (Check one best answer.) Please note: ON-SITE = within our facility
OFF-SITE = outside our facility; e.g., outreach, mobile units/vans, & other facilities
□ Specimens Collected ON-SITE and Testing performed ON-SITE
□ Specimens Collected ON-SITE & OFF-SITE and Testing performed ON-SITE
□ Specimens Collected ON-SITE & OFF-SITE and Testing performed ON-SITE & OFF-SITE
□ Specimens Collected OFF-SITE and Testing performed ON-SITE
□ Specimens Collected OFF-SITE and Testing performed OFF-SITE
□ Specimens Collected OFF-SITE and Testing performed ON-SITE & OFF-SITE
b) For Hospitals only: In what hospital setting are specimens collected? (Check all that apply.)
(Indicate all applicable sections within the hospital, as listed below)
□ Admissions □ Blood Bank □ Central Laboratory
□ Emergency Room (ER) □ Labor/Delivery □ Ward/Floor
□ Employee health/infection control □ Other Hospital Section (specify) __________
c) For Hospitals only: In what hospital setting are specimens tested? (Check all that apply.)
(Indicate all applicable sections within the hospital, as listed below)
□ Admissions □ Blood Bank □ Central Laboratory
□ Emergency Room (ER) □ Labor/Delivery □ Ward/Floor
□ Employee health/infection control □ Other Hospital Section (specify) __________
Note: Question 7d is ONLY for sites that collect specimens off-site for HIV rapid testing.
d) If you perform HIV rapid testing on specimens collected off-site (outside your facility),
please indicate where these specimens are collected. (Check all that apply.)
□ Blood/plasma donor center □ Correctional facility
(includes mobile units/vans used □ HMO
for donor blood collection) □ HIV Counseling and testing site
□ Drug use treatment center □ STD Clinic
□ Family planning center □ Health Department
□ Community Based Organization (CBO) □ Independent Laboratory
□ Medical Examiner/Coroner’s office □ Military (Other than Hospital)
□ Physician Office □ Mobile Unit/Van (other than blood donor donation)
□ Other off-site collection site (specify):_________________________________________
7. e) In which off-site settings does your organization perform rapid HIV tests?
(Check all that apply.)
□ No off-site settings
□ In a mobile facility (e.g., van)
□ In stores
□ In booths, e.g., at a health fair or festival
□ In bars or clubs
□ In bathhouses
□ On the street
□ Other setting(s) (please specify): ________________________________________
8. To detect HIV infection, do you currently perform a test in your facility other than an
HIV rapid test?
□ No Yes: (Check all that apply.)
□ Enzyme Immunoassay (EIA)
□ Western blot
□ Immunofluorescence assay
□ Other (please specify): ____________________
9. Has HIV rapid testing replaced some other method of HIV testing in your facility?
Please note: This does not refer to changing to another HIV rapid test method.
□ Yes. Specify method: □ EIA EIA kit name: _______________________________
□ Western blot (WB) WB kit name: ___________________
□ Other HIV test: ___________________________________
□ No
□ Do not know
10. Who performs HIV rapid testing in your facility on a regular basis? (Check all that apply.)
□ Physician
□ Physician Assistant
□ Nurse Practitioner
□ Person with M.S. or Ph.D. in medical or laboratory science
□ Person with Bachelors of Science/Arts in clinical laboratory science,
chemistry, biology, physics, immunology, microbiology
□ Person with Associate Degree
□ High School Graduate (with no post graduate education)
□ Medical Technologist (MT) or Clinical Laboratory Scientist/Specialist (CLS)
□ Medical Technician
□ Medical Assistant other than Medical Technologist/Technician
□ Nurse (RN/LPN)
□ Volunteer with formal medical/laboratory training
□ Volunteer with no formal medical/laboratory training
□ HIV counselor
□ Phlebotomist
□ Other (please specify): ___________________________________
11. a) How many staff in your organization are trained to do HIV rapid tests? ___________
b) What type of training is required for personnel performing HIV rapid testing in your
facility/testing site? (Check all that apply.) Please round to nearest whole numbers.
□ No training required. Go to Question 11d
□ Training by test kit manufacturer representative
Length of training: ______ hours
□ In-house training (conducted by your own facility personnel or institution)
Length of training: ______ hours
□ Training by State Health Department
Length of training: ______ hours
□ Course given by CDC or other federal agency
Length of training: ______ hours
□ Personnel must test and pass a proficiency/performance evaluation sample panel
Minimum number of samples tested:
□ Other type of training (please specify): ___________________________________
c) What is covered in the HIV RT training?
□ Reading package insert □ External quality assessment (performance
evaluation or proficiency testing [PT])
□ Practice test □ Quality Control (QC) issues
□ Standard operating procedures □ Other _____________________________
d) Is there a ‘site-specific’ Standard Operating Procedure (SOP) manual for rapid testing at the
testing site?
□ Yes
□ No
If not, why not? (Choose ONE BEST answer.)
□ Do not have an SOP for HIV RT in our facility.
□ Not familiar with SOPs.
□ We have an SOP, but it is not posted or located at the testing site.
□ We are testing in an outreach site where an SOP is inconvenient or could be
intimidating to clients/patients.
□ Other: ________________________________________________________
12. a) Is confirmatory testing performed (either in your facility or another facility) on
initially reactive (preliminary positive) HIV rapid tests?
□ Yes
□ No, Go to question 12f (page 12)
12.b) Many laboratories/testing sites use multiple tests simultaneously or in a step-wise fashion to derive an initially reactive (preliminary positive) result and/or a confirmed positive result. What is the typical algorithm, or order of tests, you use in your laboratory/testing site for HIV rapid testing and confirmatory testing? Please complete the table below by placing an ‘X’ in the boxes that correspond to your algorithm or order of tests. Check only one box for each step (row) in your algorithm. If you use less than 5 steps, leave those rows blank. For help in completing the table, please refer to the EXAMPLE in the box below of how one laboratory completed this table based on its testing algorithm.
The following is an EXAMPLE
of how to complete the table given a particular scenario. STEP
1: A patient specimen is tested using one rapid test kit. The
result is reactive. STEP
2: Specimen from the same patient is run in a second rapid test from
a different manufacturer. The
result is reactive. STEP
3: Specimen from the same patient is sent to another facility to be
run in Western blot for confirmation. The
result is confirmed positive. Two
HIV Two HIV Sequence One
HIV rapid tests, rapid tests, 2nd/3rd
HIV 2nd/3rd
HIV EIA EIA WB WB IFA IFA Other test* Other test* of
Tests Rapid simultaneously simultaneously rapid test rapid
test our other our other our other our other
Performed Test same
test kit different
kits same
test kit different
kit facility facility facility
facility facility facility facility facility
1st step [X
] [ ] [ ] [ ] [ ] [ ] [ ] [
] [ ] [ ] [ ] [ ] [ ]
2nd step [ ] [
] [ ] [ ] [X
] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [
]
3rd step [ ] [
] [ ] [ ] [ ] [ ] [ ] [ ] [X
] [ ] [ ] [ ] [ ]
4th step [ ] [ ] [
] [ ] [ ] [ ] [ ] [ ] [ ] [
] [ ] [ ] [ ]
5th step [ ] [ ] [
] [ ] [ ] [ ] [ ] [ ] [ ] [
] [ ] [ ] [ ]
*Other HIV test, please
specify:
Two HIV Two HIV
Sequence One HIV rapid tests, rapid tests, 2nd/3rd HIV 2nd/3rd HIV EIA EIA WB WB IFA IFA Other test* Other test*
of Tests Rapid simultaneously simultaneously rapid test rapid test our other our other our other our other
Performed Test same test kit different kits same test kit different kit facility facility facility facility facility facility facility facility
1st step [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ]
2nd step [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ]
3rd step [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ]
4th step [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ]
5th step [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ]
*Other HIV test, please specify:
12.c) Please complete the table below to show the algorithm you use when the secondary or confirmatory test result is negative or indeterminate (IND) AFTER an initially reactive (preliminary positive) result. What is the typical algorithm, or order of tests, you use in your laboratory/testing site for HIV rapid testing and confirmatory testing? Please complete the table below by placing an ‘X’ in the boxes that correspond to your algorithm or order of tests. Check only one box for each step (row) in your algorithm. If you use less than 5 steps, leave those rows blank. For help in completing the table, please refer to the EXAMPLE in the box below of how one laboratory completed this table based on its testing algorithm.
The following is an EXAMPLE
of how to complete the table given a particular scenario. STEP
1: A patient specimen is tested using one rapid test kit. The
result is reactive. STEP
2: Specimen from the same patient is run in a second rapid test from
a different manufacturer. The
result is negative STEP
3: Specimen from the same patient is run in a third rapid test from
a different manufacturer. The
result is positive.. STEP
4: Specimen from the same patient is sent to another facility to be
run in Western blot for confirmation. The
result is confirmed positive. Two
HIV Two HIV Sequence One
HIV rapid tests, rapid tests, 2nd/3rd
HIV 2nd/3rd
HIV EIA EIA WB WB IFA IFA Other test* Test of
Tests Rapid simultaneously simultaneously rapid test rapid
test our other our other our other our or other Outcome Performed Test same
test kit different
kits same
test kit different
kit facility facility facility
facility facility facility facility (Result)
1st step [X
] [ ] [ ] [ ] [ ] [ ] [ ] [
] [ ] [ ] [ ] [ ] Positive
2nd step [ ] [
] [ ] [ ] [X
] [ ] [ ] [ ] [ ] [ ] [ ] [
] Neg/IND
3rd step [ ] [
] [ ] [ ] [X
] [ ] [ ] [ ] [ ] [ ] [ ] [
] Positive
4th step [ ] [ ] [
] [ ] [ ] [ ] [ ] [ ] [X
] [ ] [ ] [ ] Positive
5th step [ ] [ ] [
] [ ] [ ] [ ] [ ] [ ] [ ] [
] [ ] [ ] [ ]
*Other HIV test, please
specify test and location (our facility or other facility):
Two HIV Two HIV
Sequence One HIV rapid tests, rapid tests, 2nd/3rd HIV 2nd/3rd HIV EIA EIA WB WB IFA IFA Other test* Test
of Tests Rapid simultaneously simultaneously rapid test rapid test our other our other our other our or other Outcome
Performed Test same test kit different kits same test kit different kit facility facility facility facility facility facility facility (Result)
1st step [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [Positive]
2nd step [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ Neg/IND}
3rd step [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ]
4th step [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ]
5th step [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ]
*Other HIV test, please specify test and location (our facility or other facility)
12. d) What specimen type do you use to confirm initially reactive HIV rapid test
results? (Check all that apply.)
□ Serum
□ Plasma
□ Whole blood, finger-stick
□ Whole blood, venous
□ Oral fluid (from swabbing gums)
□ Dried blood spot
□ Other (please specify): _________________________
□ Do not know
e) Which of the following procedures are used to obtain a specimen for a confirmatory test?
(Check all that apply.)
□ Specimens are used from a prior blood draw.
□ New blood specimens are taken for the confirmatory test.
□ Oral fluid specimens (from swabbing gums) are taken.
□ Other: ______________________________________
□ Do not know
Note: The following three questions (12f – 12h) refer to specimens which give an
INITIALLY negative or indeterminate rapid test result.
f) If the initial HIV rapid test result is negative or indeterminate, is further HIV testing
performed for that client/patient (either in your facility or another facility)?
□ Yes
□ No, Go to question 13.
g) What specimen type do you use to perform further HIV testing after an initial negative or indeterminate HIV rapid test result? (Check all that apply.)
□ Serum
□ Plasma
□ Whole blood, finger-stick
□ Whole blood, venous
□ Oral fluid specimens (from swabbing gums)
□ Dried blood spot
□ Other (please specify): _________________________
□ Do not know
12. h) Please list in a step-wise fashion the steps you take when further HIV testing specimens which give a negative or indeterminate initial HIV rapid test result, by placing a number on the line corresponding to the step taken.
__1__ HIV rapid test – negative/indeterminate result
_____ 2nd HIV rapid test
_____ EIA (Enzyme-linked Immuno Assay)
_____ Pooled HIV viral load (RNA) testing
_____ Other 1st HIV test (please specify): _________________________
_____ Other 2nd HIV test (please specify): _________________________
13. a) On average, how much time passes from collection of the specimen for HIV rapid
testing at your facility until preliminary positive results are reported (given) to the
client/patient? (Check only one.)
□ Less than 1 hour □ 4-8 hours
□ 1 hour □ 9-24 hours
□ between 1 and 2 hours □ 25-72 hours
□ 2-3 hours □ Other (please specify): ______________________________
b) On average, how much time passes from collection of the specimen for HIV rapid
testing at your facility until negative results are reported (given) to the client/patient?
(Check only one.)
□ Less than 1 hour □ 4-8 hours
□ 1 hour □ 9-24 hours
□ between 1 and 2 hours □ 25-72 hours
□ 2-3 hours □ Other (please specify): ______________________________
Reporting procedures for Initially Reactive (preliminary positive) HIV Rapid Tests
14. a) For Initially Reactive (preliminary positive ) HIV rapid tests, is this test result given the same day
to the patient/client (the person whose sample was tested for HIV)?
□ YES (go to question 14b)
□ NO (go to question 14c)
□ I don’t know (go to question 14d)
14. b) If “yes” to part (a): Who gives the result of the HIV rapid test to the patient/client
(the person whose sample was tested for HIV)? (Check all that apply.)
□ the person who performed the HIV rapid test.
□ the client/patient’s doctor or other health care professional responsible for the
client/patient (the person whose sample was tested for HIV).
□ a counselor (NOT the person who performed the test).
□ other (please specify):___________________________________________________
□ I don’t know
14. c) If “no” to part (a), (Check all that apply.)
□ initially reactive (preliminary positive) HIV rapid test results are NOT reported to the
client/patient (the person whose sample was tested for HIV).
□ initially reactive (preliminary positive) HIV rapid test results are NOT reported directly to
the client/patient; initially reactive results are reported ONLY AFTER CONFIRMATION.
□ initially reactive results are reported to the client/patient’s physician or other health care provider.
□ initially reactive results are reported to employee/occupational health OR infection control.
□ OTHER initially reactive result reporting procedure(s), specified:_________________________
□ I don’t know.
14. d) Where do the reporting procedures for initially reactive (preliminary positive) HIV rapid tests occur?
(Check all that apply.)
□ in our facility, in the department where HIV rapid testing is performed
□ at another area of our facility (NOT the site/department of HIV rapid testing)
□ externally (NOT at our facility)
□ I don’t know
14. e ) Do you have the same test result reporting procedures for all Reactive (preliminary positive)
HIV rapid tests? (Check only one.)
□ Yes
□ No, our result reporting procedures depend on the purpose for which
the HIV rapid test is ordered.
□ I do not know the reporting procedures for reactive (preliminary positive) HIV rapid tests
Reporting procedures for NON-Reactive HIV Rapid Test results
15. a) For NON-Reactive (Negative ) HIV rapid tests, is this test result given the same day to the
patient/client (the person whose sample was tested for HIV)?
□ YES (go to question 15b)
□ NO (go to question 15c)
□ I don’t know (go to question 15d)
15. b) If “yes” to part (a): Who gives the result of the HIV rapid test to the patient/client
(the person whose sample was tested for HIV)? (Check all that apply.)
□ the person who performed the HIV rapid test.
□ the client/patient’s doctor or other health care professional responsible for the
client/patient (the person whose sample was tested for HIV).
□ a counselor (NOT the person who performed the test).
□ other (please specify):___________________________________________________
□ I don’t know.
15. c) If “no”, please check all that apply:
□ non-reactive (negative) HIV rapid test results are NOT reported to the
client/patient (the person whose sample was tested for HIV).
□ non-reactive results are reported to the client/patient’s physician or other health care provider.
□ non-reactive results are reported to employee/occupational health OR infection control.
□ OTHER non-reactive result reporting procedure(s), specified:_________________________
□ I don’t know.
15. d) Where do the reporting procedures for non-reactive (negative) HIV rapid tests occur?
(Check all that apply.)
□ in our facility, in the department where HIV rapid testing is performed
□ at another area of our facility (NOT the site/department of HIV rapid testing)
□ externally (NOT at our facility)
□ I don’t know
15. e ) Do you have the same test result reporting procedures for all non-reactive (negative)
HIV rapid tests? (Check only one.)
□ Yes
□ No, our result reporting procedures depend on the purpose for which the HIV rapid test is ordered.
□ I do not know the reporting procedures for non-reactive (negative) HIV rapid tests
PLEASE NOTE:
The following questions on referral procedures concern procedures by which the Client/patient
(the person whose sample was tested for HIV) is referred for follow-up health care, counseling, etc.
Referral Procedures (follow-up) for client/patients after having HIV Rapid testing
16. a) For Initially Reactive (preliminary positive ) HIV rapid tests, what is the typical referral procedure
for the patient/client (the person whose sample was tested for HIV)? (Check all that apply.)
□ No referral procedure (go to question 16b)
□ Refer client to health department
□ Refer to HIV counseling center (on-site or off-site)
□ Refer to the health care provider or physician
□ Refer to employee/occupational health or infection control
□ Client is given a list of HIV resources for care
□ Client arranges own follow-up care
□ Other (please specify): _____________________________________
b) For confirmed positive HIV rapid test results:
If a client/patient has a preliminary positive rapid test that is confirmed positive,
is there a formal or informal protocol to refer this client/patient for follow-up care
(medical, counseling, etc.)? (Check all that apply.)
□ No protocol in place – referral on a case-by-case basis
□ Yes, we have a protocol/procedure for referral.
If yes, which of the following does the protocol include? (Check all that apply.)
□ Referral of client to health department
□ Refer to HIV counseling center (on-site or off-site)
□ Refer to the health care provider or physician
□ Refer to employee/occupational health or infection control
□ Client is given a list of HIV resources for care
□ Client arranges own follow-up care
□ Other (specify): ________________________________________________
c) For NON-REACTIVE HIV rapid test results:
What is the typical referral procedure for the client/patient tested? (Check all that apply.)
□ No referral procedure
□ Refer to HIV counseling center (on-site or off-site)
□ Refer to the health care provider or physician
□ Refer to employee/occupational health or infection control
□ Other (please specify): _____________________________________
Counseling procedures for client/patients after having HIV Rapid testing
17. a) Does your facility/testing site provide onsite HIV counseling to clients/patients?
□ Yes
□ No
b) At your facility/testing site, who provides client/patient consultation for initially reactive (preliminary positive) HIV rapid testing results? (Check all that apply.)
□ No counseling/consultation provided □ Physician Assistant
□ Physician □ Nurse Practitioner
□ Psychologist □ RN/LPN
□ Counselor □ Lab Tech
□ Other (please specify): _____________________
18. a) Is there a procedure at your facility to report reactive (preliminary positive) HIV rapid testing
results to an outside entity for purposes of surveillance?
□ No; Go to Question 19
□ I do not know; Go to Question 19
□ Yes.
□ Yes, but only after the HIV rapid testing results are confirmed.
If “Yes”, is reporting for surveillance mandatory? □ Yes □ No
b) What is the typical HIV rapid testing results reporting procedure for the purposes of HIV
surveillance? (Check one best answer for each column.)
Preliminary positive/reactive results
HIV positive/confirmed results
□ Report directly to Health Department □ Report directly to Health Department
□ Report to Health Department and □ Report to Health Dept. and
physician/health care provider simultaneously phys./health care provider simultaneously
□ Report to physician first; □ Report to physician first;
physician reports to Health Department physician reports to Health Department
□ Other (please specify): ________________ □ Other (please specify): _______________
□ Not reported □ Not reported
18. c) To which health department(s) do you report HIV rapid testing results?
(Check all that apply, for each column.)
Preliminary positive/reactive results HIV confirmed results
□ None □ None
□ Local □ Local
□ State/Provincial □ State/Provincial
□ Federal surveillance system □ Federal surveillance system
□ Ministry of Health/National health □ Ministry of Health/National health
authority authority
□ National Reference Laboratory □ National Reference Laboratory
□ Other (specify): _______________ □ Other (specify): _______________
□ N/A – client is referred elsewhere for
confirmatory testing (results unknown)
19. a) How often does your facility/testing site run control material purchased separately (positive or negative controls not included in the test kit) when performing HIV rapid testing? (Check all that apply.)
□ Never; Go to Question 20
□ With each run, set or batch of patient tests
□ By each new operator prior to testing client/patient specimens
□ When opening new lot number of test kits
□ When opening new box of test kits
□ Whenever new shipment of test kits is received
At periodic intervals:
□ With every shift change
□ Daily
□ Weekly
□ Monthly
□ After every _______ (number) tests; please round to nearest whole number.
□ Other _____________________________________
□ When the temperature of the test kit storage area falls outside the acceptable range stated
by the manufacturer
□ When the temperature of the testing area falls outside the acceptable range stated by the
manufacturer
b) What is the source of the above control material?
□ A different HIV rapid test kit
□ Purchased separately from same manufacturer as test kits
□ Purchased separately from different manufacturer
□ Prepared in-house
□ Other (please specify): ________________________________
20. a) In which external quality assurance (EQA) HIV rapid testing proficiency testing (PT)
or performance evaluation (PE) program(s) does your facility participate? (Check all that apply.)
□ None
□ CDC Model Performance Evaluation Program (MPEP)
□ College of American Pathologists (CAP)
□ American Association of Bioanalysts (AAB)
□ American Proficiency Institute (API)
□ New York State Department of Health Proficiency Program
□ Wisconsin State Laboratory of Hygiene Proficiency Testing Program
□ Other State Program (please specify): ________________________________
□ Provincial Program (please specify): ____________________________
□ National Program (please specify): _____________________________
□ Other (please specify): _______________________________________
b) If you are a U.S. testing site, does your site have a government-issued CLIA certificate of waiver
or another type of CLIA certificate that allows you to test? □ Yes □ No □ Not U.S. site
If yes, what type of CLIA certificate?
□ Certificate of waiver □ Registration certificate
□ Certificate of compliance □ Certificate for provider-performed microscopy
□ Certificate of accreditation
c) Who performs proficiency testing or performance evaluation testing for HIV rapid testing
in your testing site? (Check all that apply.)
□ Medical Technologist/Clinical Laboratory Scientist
□ Medical Technician
□ Person with BS/BA in laboratory science
□ HIV Counselor
□ Person with Associate Degree
□ Nurse/Nurse Practitioner
□ Other: _____________________________________________
21. a) Approximately how much does your facility charge to perform an HIV rapid test?
(Round off to nearest U.S. Dollar. Put $0.00 in the box if there is no charge.)
$
□ Variable fee schedule: ___________________________________________
b) Do you accept insurance reimbursement only, so that there is no actual charge to the patient?
□ Yes
□ No
□ N/A – all testing is free (no charge)
□ I don’t know
22. a) In your opinion, what are the advantages and disadvantages of HIV rapid testing for
patient/clients, as compared to traditional, non-rapid HIV testing? (check all that apply)
□ In comparison to traditional HIV tests, rapid tests increase clients’ anxiety about HIV.
□ It is easy to explain the rapid test to clients with low literacy skills.
□ Clients may not feel prepared to receive HIV test results so quickly.
□ Rapid testing allows more people to know their HIV status.
b) In your opinion, what are the administrative advantages and disadvantages of
HIV rapid testing, as compared to traditional, non-rapid HIV testing? (check all that apply)
□ My organization’s administration encourages the use of rapid tests.
□ Rapid tests have been easily integrated into my organization.
□ Rapid test kits cost too much.
□ It is expensive to start up a rapid testing program.
□ It was difficult to design a rapid testing protocol for my organization.
□ Other: ________________________________________________________
c) In your opinion, what are the advantages and disadvantages of HIV rapid testing
when used in field settings such as mobile units/vans? (check all that apply)
□ It is difficult to maintain client confidentiality in field settings.
□ Test kit temperatures are hard to regulate in field settings.
□ It is challenging to read rapid test results in field settings.
□ Rapid HIV tests are more appropriate to use in the field than non-rapid HIV tests.
□ My organization is unable to provide confirmatory tests to clients in the field.
Thank you for your participation!
File Type | application/msword |
File Title | Survey of Laboratory Practices for Rapid HIV Testing |
Author | PHPPO |
Last Modified By | kls6 |
File Modified | 2006-11-07 |
File Created | 2006-05-22 |